Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancer. - Levy,T.; Inbar,M.; Menczer,J.; Grisaru,D.; Glezerman,M.; Safra,T. (Gynecol Oncol, 2004)